|
CN112263562A
|
|
Preparation method of celecoxib capsule composition
|
|
CN112162045A
|
|
Method for detecting 2-chloropropane in memantine hydrochloride
|
|
CN110354090A
|
|
A kind of diabecron sustained-release tablet and preparation method thereof
|
|
CN106309362A
|
|
Pentoxifylline injection composition and preparation method thereof
|
|
CN106138004A
|
|
A kind of Pentoxifylline sustained release tablets and preparation method thereof
|
|
CN105919960A
|
|
Roxithromycin dispersible tablets and preparation method thereof
|
|
CN105640895A
|
|
Cefadroxil granular preparation and preparation method thereof
|
|
CN105534937A
|
|
Cefadroxil tablet and preparation method thereof
|
|
CN105496984A
|
|
Cefixime capsule stable in quality and preparation method thereof
|
|
CN105193762A
|
|
Aspirin enteric coated tablet and preparation method thereof
|
|
CN105125514A
|
|
Stable enalapril maleate capsules and preparation method thereof
|
|
CN104910222A
|
|
Azithromycin new crystal-form compound and preparation method thereof
|
|
CN105030704A
|
|
Azithromycin tablet and preparation method thereof
|
|
CN104829662A
|
|
Azithromycin related substance preparation method
|
|
CN104523710A
|
|
Compound clopidogrel hydrogen sulphate and aspirin double-layer tablet and preparation method thereof
|
|
CN104356042A
|
|
New solid oxiracetam as well as preparation method, application and medicament thereof
|
|
CN104326970A
|
|
L-amlodipine maleate compound, and preparation method and medicinal preparation thereof
|
|
CN104000815A
|
|
Pharmaceutical composition containing 4-hydroxide radical-2-oxo-1-pyrrolidine acetamide and application thereof
|
|
CN103877081A
|
|
Medicinal composition containing 4-hydroxy-2-oxo-1-pyrrolidine acetamide and application thereof
|
|
CN103695379A
|
|
Recombinant ketoreductase and method for preparing oxiracetam intermediate compound by using same
|
